Antibacterial Resistance Leadership Group

@ARLGnetwork

Experts dedicated to prioritizing, designing, and executing clinical research that will reduce the public health threat of antibacterial resistance.

arlg.org Joined September 2019

351 Following 1.2K Followers 1K Posts

Latest posts 5

Antibacterial Resistance Leadership Group @ARLGnetwork 13h

The #ARLGnetwork RADICAL study investigated a simplified test that measures a patient’s gene activity to rapidly determine whether an illness is bacterial or viral, helping to prevent the overuse of antibiotics & decrease antibiotic resistance. Learn more: duke.is/ARLG-RADICAL

Summary of Results
RADICAL
Rapid Diagnostics in Categorizing Acute Lung Infections

ARLG
Antibacterial Resistance Leadership Group

Antibacterial Resistance Leadership Group @ARLGnetwork 6d

New in @CIDJournal: #ARLGnetwork researchers developed an anaerobic activity index that assigns numeric scores to common antibiotics. The AAI may be used as a research tool to evaluate the impact of anti-anaerobic antibiotics on patient outcomes🔗 duke.is/ARLG-publicati…

Manuscript Published in Clinical Infectious Diseases, "Development and Application of an Anaerobic Activity Index," Mackow N A, Komarow L, Napravnik S, et al. Natalie Mackow, M D, M S C R, Infectious Diseases Physician, Stony Brook Medicine, A R L G Fellow. A R L G - Antibacterial Resistance Leadership Group.

Antibacterial Resistance Leadership Group @ARLGnetwork Nov 3

🎉 Study Milestone: Manuscript accepted for DIFFR, led by #ARLGnetwork mentee Sixto Manuel Leal, Jr., MD, PhD. The study evaluated a novel molecular diagnostic approach to detect Clostridioides difficile mRNA in stool. Learn more about ARLG studies🔗arlg.org/arlg-studies

Study Milestone - Manuscript Accepted. DIFFR - Improved molecular diagnostic approaches to detect Clostridioides difficile. A R L G - Antibacterial Resistance Leadership Group.

Antibacterial Resistance Leadership Group @ARLGnetwork Oct 29

📢 Check your email for an invitation to the #ARLGnetwork Grand Rounds on Friday, Nov. 6, 4-5 pm ET: Modern Management of MDROs – What Has Changed and What Hasn't? Presented by Susan Huang, MD, MPH, @UCIrvineHealth and moderated by Sarah Doernberg, MD, MAS, FIDSA, @UCSFHospitals.

A R L G Grand Rounds - Friday, November 6, 4-5 p.m. ET.
Modern Management of M D R Os - What Has Changed and What Hasn't?
Presented by Susan S. Huang, MD, MPH, University of California Irvine. Moderated by Sarah Doernberg, MD, MAS, FIDSA, University of California San Francisco, A R L G Steering Committee Chair.

Antibacterial Resistance Leadership Group @ARLGnetwork Oct 27

An #ARLGnetwork MDRO study in @BioMedCentral Infectious Diseases found distinct molecular patterns & poor outcomes in carbapenem-resistant gram-negative infections, underscoring the importance of #AMR surveillance, collaboration, & future studies 🔗 duke.is/ARLG-publicati…

Manuscript Published in BMC Infectious Diseases, "Distinct Molecular Epidemiology and Outcomes of Carbapenem-Resistant Gram-Negative Infections in Lebanon: Insights from the MDRO Network," Jabbour J F, Kadri H, Jabra E, et al. A R L G - Antibacterial Resistance Leadership Group